Consistent with the increased expression of IL-23R and markers of activation (CD69 and GITR expression), the number of CD45Ro cells that co-expressed IL-17 was significantly increased in all SSc patients investigated (P<0.0001, Figure 2b). Here, TNFRSF18 is linked to systemic sclerosis.